» Articles » PMID: 20871098

Mitofusin 1 and Mitofusin 2 Are Ubiquitinated in a PINK1/parkin-dependent Manner Upon Induction of Mitophagy

Overview
Journal Hum Mol Genet
Date 2010 Sep 28
PMID 20871098
Citations 479
Authors
Affiliations
Soon will be listed here.
Abstract

Mitochondrial dysfunction and perturbed degradation of proteins have been implicated in Parkinson's disease (PD) pathogenesis. Mutations in the Parkin and PINK1 genes are a cause of familial PD. PINK1 is a putative kinase associated with mitochondria, and loss of PINK1 expression leads to mitochondrial dysfunction, which increases with time. Parkin is suggested to be downstream of PINK1 and also mediates the removal of damaged mitochondria by macroautophagy (mitophagy). We investigated whether mitochondrial dysfunction in dopaminergic SH-SY5Y cells following decreased PINK1 expression by RNAi may in part be due to the inhibition of mitophagy. Reduced flux through the macroautophagy pathway was found to be coincident with the inhibition of ATP synthesis following 12 days of PINK1 silencing. Overexpression of parkin in these cells restored both autophagic flux and ATP synthesis. Overexpression and RNAi studies also indicated that PINK1 and parkin were required for mitophagy following CCCP-induced mitochondrial damage. The ubiquitination of several mitochondrial proteins, including mitofusin 1 and mitofusin 2, were detected within 3 h of CCCP treatment. These post-translational modifications were reduced following the silencing of parkin or PINK1. The ubiquitination of mitochondrial proteins appears to identify mitochondria for degradation and facilitate mitophagy. PINK1 and parkin are thus required for the removal of damaged mitochondria in dopaminergic cells, and inhibition of this pathway may lead to the accumulation of defective mitochondria which may contribute to PD pathogenesis.

Citing Articles

Mitochondrial Involvement in the Pathogenesis of Endometriosis and its Potential as Therapeutic Targets.

Shen D, Qi C, Hu P, Li J, Shen Y Reprod Sci. 2025; .

PMID: 40064837 DOI: 10.1007/s43032-025-01827-5.


Calcium-mediated regulation of mitophagy: implications in neurodegenerative diseases.

Borbolis F, Ploumi C, Palikaras K NPJ Metab Health Dis. 2025; 3(1):4.

PMID: 39911695 PMC: 11790495. DOI: 10.1038/s44324-025-00049-2.


Targeting Mitochondria in Glioma: New Hopes for a Cure.

Gatto L, Di Nunno V, Ghelardini A, Tosoni A, Bartolini S, Asioli S Biomedicines. 2025; 12(12.

PMID: 39767637 PMC: 11727304. DOI: 10.3390/biomedicines12122730.


Mitochondrial quality control: the real dawn of intervertebral disc degeneration?.

Qiu B, Xie X, Xi Y J Transl Med. 2024; 22(1):1126.

PMID: 39707402 PMC: 11662537. DOI: 10.1186/s12967-024-05943-9.


Mitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy.

Oyovwi M, Ugwuishi E, Udi O, Uchechukwu G J Mol Neurosci. 2024; 74(4):107.

PMID: 39514132 DOI: 10.1007/s12031-024-02280-w.


References
1.
Wood-Kaczmar A, Gandhi S, Yao Z, Abramov A, Abramov A, Miljan E . PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS One. 2008; 3(6):e2455. PMC: 2413012. DOI: 10.1371/journal.pone.0002455. View

2.
Grunewald A, Gegg M, Taanman J, King R, Kock N, Klein C . Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol. 2009; 219(1):266-73. DOI: 10.1016/j.expneurol.2009.05.027. View

3.
Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, Gispert S . Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci. 2007; 27(45):12413-8. PMC: 6673250. DOI: 10.1523/JNEUROSCI.0719-07.2007. View

4.
Gegg M, Cooper J, Schapira A, Taanman J . Silencing of PINK1 expression affects mitochondrial DNA and oxidative phosphorylation in dopaminergic cells. PLoS One. 2009; 4(3):e4756. PMC: 2649444. DOI: 10.1371/journal.pone.0004756. View

5.
Pan T, Kondo S, Le W, Jankovic J . The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease. Brain. 2008; 131(Pt 8):1969-78. DOI: 10.1093/brain/awm318. View